WO2003047558A3 - Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase inhibitors - Google Patents
Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase inhibitors Download PDFInfo
- Publication number
- WO2003047558A3 WO2003047558A3 PCT/IB2002/004805 IB0204805W WO03047558A3 WO 2003047558 A3 WO2003047558 A3 WO 2003047558A3 IB 0204805 W IB0204805 W IB 0204805W WO 03047558 A3 WO03047558 A3 WO 03047558A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oxidase
- amino acid
- inhibitors
- treatment
- cns disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002339696A AU2002339696A1 (en) | 2001-12-03 | 2002-10-29 | Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase inhibitors |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33658301P | 2001-12-03 | 2001-12-03 | |
US60/336,583 | 2001-12-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003047558A2 WO2003047558A2 (en) | 2003-06-12 |
WO2003047558A3 true WO2003047558A3 (en) | 2004-03-25 |
Family
ID=23316743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2002/004805 WO2003047558A2 (en) | 2001-12-03 | 2002-10-29 | Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase inhibitors |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002339696A1 (en) |
WO (1) | WO2003047558A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9485988B2 (en) | 2008-06-26 | 2016-11-08 | Suncor Energy Inc. | Turfgrass fungicide formulation with pigment |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2529486A1 (en) * | 2003-06-18 | 2004-12-23 | Nst Neurosurvival Technologies Ltd. | Method for selective targeting of apoptotic cells and small molecule ligands used thereof |
CA2472806A1 (en) | 2004-05-18 | 2005-11-18 | Petro-Canada | Compositions and methods for treating turf insect pests and diseases such as fungal infestations |
US20060111442A1 (en) * | 2004-11-20 | 2006-05-25 | Mr. Stanley Antosh | Use of methyl pyruvate to increase cellular energy production downstream of glycolysis for the PARP-1 ablation of HIV without necrotic cell death caused by continuous, chronic PARP-1 activation through the concomitant depletion of ATP and NAD. |
US20100048713A1 (en) * | 2006-01-06 | 2010-02-25 | Aarhus Universitet | Compounds acting on the serotonin transporter |
US9357768B2 (en) | 2006-10-05 | 2016-06-07 | Suncor Energy Inc. | Herbicidal composition with increased herbicidal efficacy |
FR2929115B1 (en) * | 2008-03-31 | 2010-06-04 | Exsymol Sa | COSMETIC USE OF CONJUGATED COMPOUNDS OF INDOLIC AUXINS. |
CA3037010A1 (en) | 2009-01-20 | 2010-07-29 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Cente | Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical |
EP2613635B1 (en) | 2010-09-09 | 2016-04-06 | Suncor Energy Inc. | Synergistic paraffinic oil and boscalid fungicides |
JO3115B1 (en) | 2011-08-22 | 2017-09-20 | Takeda Pharmaceuticals Co | Pyridazinone Compounds and Their Use as DAAO Inhibitors |
US9889222B2 (en) | 2011-11-09 | 2018-02-13 | Kimberly-Clark Worldwide, Inc. | Aqueous medium-sensitive coating compositions for triggered release of active ingredients and visual indication for wetness |
US8791045B2 (en) | 2011-11-09 | 2014-07-29 | Kimberly-Clark Worldwide, Inc. | Non-tacky wetness indicator composition for application on a polymeric substrate |
AU2012337781B2 (en) | 2011-11-15 | 2017-07-06 | Takeda Pharmaceutical Company Limited | Dihydroxy aromatic heterocyclic compound |
US9585826B2 (en) | 2012-11-07 | 2017-03-07 | Kimberly-Clark Worldwide, Inc. | Triggerable compositions for two-stage, controlled release of active chemistry |
GB201222711D0 (en) | 2012-12-17 | 2013-01-30 | Takeda Pharmaceutical | Novel compounds |
US9119780B2 (en) | 2013-10-30 | 2015-09-01 | Kimberly-Clark Worldwide, Inc. | Triggerable compositions for two-stage, controlled release of proactive chemistry |
GB201403944D0 (en) * | 2014-03-06 | 2014-04-23 | Takeda Pharmaceutical | New use |
BR112017025499A2 (en) * | 2015-05-28 | 2018-08-07 | Baylor College Medicine | Benefits Of N-Acetyl Cysteine And Glycine Supplementation To Improve Glutathione Levels |
CA2938096C (en) | 2016-08-04 | 2019-02-26 | Suncor Energy Inc. | Stabilized emulsions |
CN108420810A (en) * | 2018-02-11 | 2018-08-21 | 华南农业大学 | Phenylpyruvic acid is preparing the application in alleviating or improving the product of anxiety and Depressive behavior |
RU2751003C1 (en) * | 2020-07-29 | 2021-07-07 | Федеральное государственное бюджетное образовательное учреждение высшего образования «Московский государственный университет имени М.В.Ломоносова» (МГУ) | Use of sulfonates for inhibiting human lactate dehydrogenase a |
CN115745848A (en) * | 2022-12-07 | 2023-03-07 | 上海优合生物科技有限公司 | Processing and synthesizing process of aminoguanidine |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0950406A2 (en) * | 1998-01-26 | 1999-10-20 | Niigata University | Remedy for CAG repeat expansion diseases |
WO1999065516A1 (en) * | 1998-06-17 | 1999-12-23 | Yeda Research And Development Co. Ltd. | Methods and compositions for treating diseases mediated by transglutaminase activity |
WO2000011952A1 (en) * | 1998-08-31 | 2000-03-09 | Pro-Neuron, Inc. | Compositions and methods for treatment of mitochondrial diseases |
WO2001009118A2 (en) * | 1999-07-29 | 2001-02-08 | Patrick T Prendergast | Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement |
WO2002066672A2 (en) * | 2001-01-16 | 2002-08-29 | Genset S.A. | Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
-
2002
- 2002-10-29 AU AU2002339696A patent/AU2002339696A1/en not_active Abandoned
- 2002-10-29 WO PCT/IB2002/004805 patent/WO2003047558A2/en not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0950406A2 (en) * | 1998-01-26 | 1999-10-20 | Niigata University | Remedy for CAG repeat expansion diseases |
WO1999065516A1 (en) * | 1998-06-17 | 1999-12-23 | Yeda Research And Development Co. Ltd. | Methods and compositions for treating diseases mediated by transglutaminase activity |
WO2000011952A1 (en) * | 1998-08-31 | 2000-03-09 | Pro-Neuron, Inc. | Compositions and methods for treatment of mitochondrial diseases |
WO2001009118A2 (en) * | 1999-07-29 | 2001-02-08 | Patrick T Prendergast | Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement |
WO2002066672A2 (en) * | 2001-01-16 | 2002-08-29 | Genset S.A. | Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
Non-Patent Citations (4)
Title |
---|
BEERS M H ET AL.: "The Merck Manual, 17th ed.", 1999, MERCK RESEARCH LABORATORIES, WHITEHOUSE STATION, N.J., XP002246495 * |
GISPERT S ET AL: "Localization of the candidate gene D-amino acid oxidase outside the refined I-cM region of spinocerebellar ataxia 2.", AMERICAN JOURNAL OF HUMAN GENETICS. UNITED STATES OCT 1995, vol. 57, no. 4, October 1995 (1995-10-01), pages 972 - 975, XP009013160, ISSN: 0002-9297 * |
LARSON JEFFREY L ET AL: "The toxicity of repeated exposures to rolipram, a type IV phosphodiesterase inhibitor, in rats.", PHARMACOLOGY & TOXICOLOGY, vol. 78, no. 1, 1996, pages 44 - 49, XP009013100, ISSN: 0901-9928 * |
PHANJOO A L ET AL: "Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people", ACTA PSYCHIATRICA SCANDINAVICA 1991 DENMARK, vol. 83, no. 6, 1991, pages 476 - 479, XP009013266, ISSN: 0001-690X * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9485988B2 (en) | 2008-06-26 | 2016-11-08 | Suncor Energy Inc. | Turfgrass fungicide formulation with pigment |
Also Published As
Publication number | Publication date |
---|---|
AU2002339696A8 (en) | 2003-06-17 |
WO2003047558A2 (en) | 2003-06-12 |
AU2002339696A1 (en) | 2003-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003047558A3 (en) | Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase inhibitors | |
AU3998400A (en) | Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor | |
WO2002072031A3 (en) | Substituted tetracycline compounds as synergistic antifungal agents | |
WO2001079458A3 (en) | Polypeptides having haloperoxidase activity | |
WO2001017543A3 (en) | Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer | |
WO2002041889A3 (en) | Indolsulfonyl compounds useful in the treatment of cns disorders | |
WO1999043651A3 (en) | Inhibitors of phospholipase enzymes | |
AU2001260400A1 (en) | Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders | |
WO2002046129A3 (en) | Inhibitors of histone deacetylase | |
WO2002066672A3 (en) | Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists | |
WO2003000200A3 (en) | β-2'-OR 3'-HALONUCLEOSIDES | |
AU2001233081A1 (en) | Composition for treatment of stress | |
WO2001035950A3 (en) | Benzamide therapeutics and methods for treating inflammatory bowel disease | |
MXPA04004939A (en) | 3-alkylated-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthols and 3,3'-dialkylated-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthols and processes for making them. | |
AU2002243023A1 (en) | Compositions for preventing and/or treating oral diseases | |
WO2003099217A3 (en) | Methods of treating bacterial infections and diseases associated therewith | |
WO2002094189A3 (en) | Compositions and methods for treating or preventing convulsions or seizures | |
WO2002007669A3 (en) | Phospholipid derivatives of valproic acid and mixtures thereof | |
WO2004032908A3 (en) | Method of inhibiting angiogenesis | |
AU2002367023A1 (en) | Compositions and methods for treating heart failure | |
WO2002039122A3 (en) | Methods for the identification and the treatment of cardiovascular disease | |
WO2003066022A3 (en) | Stable pharmaceutical composition useful for treating gastrointestinal disorders | |
WO2000040232A3 (en) | Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions | |
AU2002365057A1 (en) | Compositions and methods for treating heart failure | |
WO2002041831A3 (en) | Inositol derivatives for increasing chloride secretion and inhibiting inflammation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |